### 8374 Federal Register / Vol. 75, No. 36 / Wednesday, February 24, 2010 / Notices

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**National Institutes of Health**

**National Human Genome Research Institute; Notice of Closed Meeting** 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Human Genome Research Institute Special Emphasis Panel, Revolutionary Sequencing Technology.

Date: April 2, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications.

Place: Crystal City Marriott at Regan National Airport, 1999 Jefferson Davis Highway, Arlington, VA 22202.

Contact Person: Ken D. Nakamura, PhD, Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, 301–402–0838, nakamurk@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

Dated: February 17, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–3736 Filed 2–23–10; 8:45 am]

**BILLING CODE 4140–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**National Institutes of Health**

**National Institute on Aging; Notice of Closed Meetings** 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee : National Institute on Aging Special Emphasis Panel, New Invertebrate Models for the Biology of Aging.

Date: March 18, 2010.
Time: 8:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications.

Place: Embassy Suites Hotel, Chevy Chase Pavilion, 4300 Military Road, NW., Bethesda,
MD 20892.

Contact Person: Elaine Lewis, PhD, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Building, Suite 2C212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892.

301–402–7707. elainelewis@nia.nih.gov

.

Name of Committee: National Institute on Aging Special Emphasis Panel, ADNI2.

Date: March 30, 2010.
Time: 1 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892. (Telephone Conference Call.)

Contact Person: Elaine Lewis, PhD, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Building, Suite 2C212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892.

301–402–7707. elainelewis@nia.nih.gov

.

Name of Committee: National Institute on Aging Special Emphasis Panel, Behavioral Economics, Health and Aging.

Date: March 31, 2010.
Time: 9 a.m. to 1 p.m. Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892. (Telephone Conference Call.)

Contact Person: Rebecca J. Ferrell, PhD, Scientific Review Officer, National Institute on Aging, Gateway Building 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892.

301–402–7703. ferrellrj@mail.nih.gov

. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: February 17, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010–3695 Filed 2–23–10; 8:45 am]

**BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Centers for Medicare & Medicaid Services** 

**[CMS–1566–CN]**

**Medicare Program; Meeting of the Practicing Physicians Advisory**  **Council, March 8, 2010; Correction**

**AGENCY :**  Centers for Medicare & Medicaid Services (CMS), HHS.

**ACTION :**  Correction of notice.

**SUMMARY :**  This document corrects technical errors that appeared in the meeting notice published in the Federal Register on Friday, January 22, 2010 entitled ‘‘ Medicare Program; Meeting of the Practicing Physicians Advisory Council, March 8, 2010. ’’

**FOR FURTHER INFORMATION CONTACT :**  Kelly Buchanan, DFO, (410) 786–6132, or e-mail PPAC

_ hhs@cms.hhs.gov. News media representatives must contact the CMS Press Office, (202) 690– 6145. Please refer to the CMS Advisory Committees’ Information Line (1–877– 449–5659 toll free), (410) 786–9379 local) or the Internet at http:// www.cms.hhs.gov/home/ regsguidance.asp for additional information and updates on committee activities.

**SUPPLEMENTARY INFORMATION :**  I. Background

In FR Doc. 2010–1333 of January 22, 2010 (75 FR 3743), there were a number of technical errors that are identified and corrected in the ‘‘ Correction of Errors ’’ section below. II. Summary of Errors

In section III. of the notice, ‘‘ Meeting Registration and Security Information ’’

, we inadvertently included security information for the Hubert H. Humphrey building instead of the CMS central office. Therefore, we are removing section III. in its entirety and replacing the language as noted in section III. of this notice.

III. Correction of Errors

In FR Doc. 2010–1333 of January 22, 2010 (75 FR 3743), replace section III. in its entirety with the following language:
III. Meeting Registration and Security Information

The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register by contacting the DFO at the address listed in the **ADDRESSES** section of this notice or by telephone at the number listed in the

**FOR FURTHER INFORMATION CONTACT** section of this notice by the date specified in the **DATES** section of this notice.


### 8375 Federal Register / Vol. 75, No. 36 / Wednesday, February 24, 2010 / Notices

Individuals requiring sign language interpretation or other special accommodations must contact the DFO via the contact information specified in the **FOR**
**FURTHER INFORMATION CONTACT** section of this notice by the date listed in the **DATES** section of this notice.

This meeting will be held in a Federal government building; therefore, Federal security measures are applicable. We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following:

• Presentation of government-issued photographic identification to the Federal Protective Service or Guard Service personnel.

• Inspection of vehicle’s interior and exterior (this includes engine and trunk inspection) at the entrance to the grounds. Parking permits and instructions will be issued after the vehicle inspection.

• Inspection, via metal detector or other applicable means of all persons brought entering the building. We note that all items brought into CMS, whether personal or for the purpose of presentation or to support a presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation.

Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 45 minutes prior to the convening of the meeting.

All visitors must be escorted in areas other than the lower and first floor levels in the Central Building.

Authority: (Section 1868 of the Social Security Act (42 U.S.C. 1395ee) and section 10(a) of Pub. L. 92–463 (5 U.S.C. App. 2, section 10(a)).)

Dated: February 18, 2010. Charlene Frizzera, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2010–3693 Filed 2–19–10; 4:15 pm]

**BILLING CODE 4120–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Food and Drug Administration**

**[Docket No. FDA–2010–N–0080]**

**Device Improvements to Reduce Unnecessary Radiation Exposure From**  **Medical Imaging; Public Meeting; Request for Comments** 

**AGENCY :**  Food and Drug Administration, HHS.

**ACTION :**  Notice of public meeting; request for comments. The Food and Drug Administration (FDA) is announcing a public meeting entitled: ‘‘ Device Improvements to Reduce Unnecessary Radiation Exposure From Medical Imaging. ’’ The purpose of this meeting is to discuss steps that could be taken by manufacturers of devices used in computed tomography (CT) and in fluoroscopy that would help reduce unnecessary patient exposure to ionizing radiation during CT and fluoroscopic procedures. FDA is seeking input on this topic and requests comments on a number of related questions.

Dates and Time : The public meeting will be held on March 30 and 31, 2010, from 8 a.m. to 5 p.m. Persons interested in attending and/or participating in the meeting must register by 5 p.m. on March 15, 2010. Submit written or electronic comments by April 15, 2010.

Location : The public meeting will be held at the Holiday Inn Gaithersburg, 2 Montgomery Village Ave., Gaithersburg, MD 20879. The meeting will not be videotaped or webcast.

Contact Person : Simon Choi, Food and Drug Administration, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5400, Silver Spring, MD 20993–0002, 301– 796–5426, e-mail: simon.choi@fda.hhs.gov

.

Registration : If you wish to attend thepublic meeting, you must register by emailing CDRHimaging initiative@fda.hhs.gov. Provide complete contact information for each attendee, including name, title,company or organization, address, email, and telephone number. Registration requests must be received by March 15, 2010.

If you wish to make an oral presentation during any of the sessions at the meeting (see section II of this document, Public Meeting), you must indicate this at the time of registration. FDA has included specific questions for comment in section III of this document, Questions for Comment. You should also identify the session(s) during which you would like to present, as well as the question(s) you would like to address in each session. In order to keep each session focused on the topic at hand, presentations given during each session should address only the topic specified for that session. FDA will do its best to accommodate requests to speak. Individuals and organizations with common interests are urged to consolidate or coordinate their presentations, and to request time for a joint presentation. FDA will determine the amount of time allotted to each presenter and the approximate time that each oral presentation is scheduled to begin.

If you would like to participate in any of the four planned roundtable discussions (see section II of this document, Public Meeting), you must indicate this interest at the time of registration, and also submit a brief statement that describes your experience with CT or fluoroscopic devices. FDA is seeking participants interested in engaging in one of four wrap-up roundtable discussions related to the presentations given during each of the earlier sessions of the meeting. Each roundtable discussion will include no more than 10 nonFDA participants. Only one participant from an organization or company will be assigned to each discussion group. FDA will attempt to have a range of constituencies represented in each discussion group. Others in attendance at the public meeting will have an opportunity to listen to each roundtable discussion.

Registration is free and will be on a first-come, first-served basis. Early registration is recommended because seating is limited. FDA may limit the number of participants from each organization based on space limitations. Registrants will receive confirmation once they have been accepted. Onsite registration on the day of the publicmeeting will be provided on a spaceavailable basis beginning at 7 a.m.

If you need special accommodations due to a disability, please contact Simon Choi at 301–796–5426, simon.choi@fda.hhs.gov at least 7 days in advance of the meeting.

Comments : FDA is holding this public meeting to obtain information on a number of questions regarding steps manufacturers of CT and fluoroscopic devices could take to help reduce unnecessary patient exposure to ionizing radiation from these medical imaging modalities. The deadline for submitting comments related to this public meeting is April 15, 2010.

Regardless of attendance at the public meeting, interested persons may submit written or electronic comments. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to http:// www.regulations.gov. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. In addition, when